This website is intended for US residents only.

About peripheral
T-cell lymphoma

Learn more about your cancer and see how
ADCETRIS could help

Peripheral T-cell lymphomas are a type of non-Hodgkin lymphoma that develop from white blood cells called T cells. T cells are part of the body’s immune system. When working properly, the immune system helps your body fight off the infections and diseases, including cancer.

The importance of CD30

ADCETRIS is a CD30-directed treatment. This means that it works by finding and destroying cells that have CD30, a protein that can be found on certain peripheral T-cell lymphoma cells.

Even though CD30 is not usually found on healthy cells, ADCETRIS may affect them and cause side effects.

If your cancer cells have CD30, you may benefit from treatment with ADCETRIS.

Testing for CD30 protein

Depending on your T-cell lymphoma diagnosis, your doctor may order a test to find out how much CD30 is on your cancer cells. In some cases, the test result may be negative, meaning that your doctor may conclude that CD30 protein was not found. In reality, the amount of CD30 may just be very low.

Any amount of CD30, even as low as 1%, means that ADCETRIS could be a treatment option for you

If your doctor says that the CD30 test results are negative, ask them to check if there is any CD30 protein present on your cancer cells, no matter how low.

Have you recently been diagnosed with peripheral T-cell lymphoma?

There are many types of peripheral T-cell lymphomas, each with different characteristics. Different types include:

  • Adult T-cell lymphoma/leukemia
  • Angioimmunoblastic T-cell lymphoma
  • Enteropathy-associated T-cell lymphoma
  • Peripheral T-cell lymphoma not otherwise specified
  • Cutaneous T-cell lymphomas
  • Systemic anaplastic large cell lymphoma

See how ADCETRIS plus chemotherapy worked in adults newly diagnosed with systemic anaplastic large cell lymphoma or other CD30-expressing T-cell lymphomas.

Relapsed primary cutaneous anaplastic large cell lymphoma and mycosis fungoides

Primary cutaneous anaplastic large cell lymphoma and mycosis fungoides are 2 different types of cutaneous T-cell lymphoma, a type of blood cancer that involves the skin.

  • Mycosis fungoides is the most common type of cutaneous T-cell lymphoma, occurring in about 50% of cases
  • Primary cutaneous anaplastic large cell lymphoma happens less often

If your cancer has come back, there are still treatments that can help.

See how ADCETRIS worked in adults with relapsed primary cutaneous anaplastic large cell lymphoma or CD30-expressing mycosis fungoides.

Relapsed systemic anaplastic large cell lymphoma

Systemic anaplastic large cell lymphoma is a fast-growing type of T-cell lymphoma. It may appear in the skin, lymph nodes, bones, soft tissues, lungs, or liver. Its cancer cells have CD30 protein on them.

Anaplastic large cell lymphomas comprise about 1% of all non-Hodgkin lymphomas and about 10% of all T-cell lymphomas.

If your cancer comes back after combination chemotherapy, there are treatments that can help.

See how ADCETRIS worked in adults with relapsed systemic anaplastic large cell lymphoma.

Glossary

Relapse: When cancer has returned after a period of remission.

Remission: When signs and symptoms of cancer are reduced or have disappeared.

Interested in starting ADCETRIS?

Important Safety Information

What is the most important serious safety information I should know about ADCETRIS?

  • PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML): Patients treated with ADCETRIS can have a rare, serious brain infection called PML. It can cause death. Symptoms can begin at different times after starting ADCETRIS treatment, some within 3 months after the first dose. Call your doctor if you have mood changes, confusion, dizziness or loss of balance, trouble talking or walking, vision changes, or if you feel weak or have weakness on one side of the body. PML could also be caused by other treatments or diseases that made your immune system weaker.

What should I avoid when receiving ADCETRIS?

  • Do not take ADCETRIS with bleomycin because of possible serious side effects to the lungs.

What are the other possible serious side effects of ADCETRIS?

A serious side effect can be life-threatening or can lead to death. They may happen during treatment or after your treatment has ended.

Call your doctor right away if you have symptoms of a serious side effect or if your symptoms get worse. If you have a serious side effect, your doctor may delay or stop your ADCETRIS treatment.

  • Nerve damage (peripheral neuropathy) that is mostly numbness or tingling in the hands or feet (sensory) and/or weakness in the arms or legs (motor). The nerve damage can get worse with more doses of ADCETRIS. Call your doctor if you have tingling, burning, or numbness in your hands or feet, changes in your sense of touch, or trouble moving your hands or feet.
  • Allergic and infusion reactions during infusion or up to 24 hours after your ADCETRIS infusion. Call your doctor if you have fever, chills, rash, or breathing problems within 24 hours of your infusion.
  • Blood problems such as a low number of white blood cells with or without fever, a low number of platelets, or a low number of red blood cells.

    Your doctor will do blood tests to check your blood cell levels during ADCETRIS treatment. If your levels are too low, your doctor may lower or delay your dose, stop your ADCETRIS treatment, or give you a medicine called G-CSF. G-CSF is meant to prevent you from having a low number of white blood cells.

  • Infections such as pneumonia, bacteremia, and sepsis or septic shock can happen with ADCETRIS treatment. Call your doctor if you have a fever of 100.5°F or higher, chills, cough, or pain when you urinate.
  • Tumor lysis syndrome can happen if you have a tumor that grows quickly or have many tumor cells in your body.
  • Patients with severe kidney disease may have more side effects and deaths than patients with normal kidney function and should avoid treatment with ADCETRIS.
  • Patients with moderate or severe liver disease may have more side effects and deaths than patients with normal liver function and should avoid treatment with ADCETRIS.
  • Liver injury can happen after the first dose of ADCETRIS or after ADCETRIS treatment is stopped and started again. Call your doctor if you feel tired, do not feel like eating, have upper stomach pain, dark urine, or yellow skin and eyes (jaundice).
  • Lung problems. Call your doctor if you have a new cough, a cough that gets worse, or feel out of breath.
  • Skin problems called Stevens-Johnson syndrome and toxic epidermal necrolysis can happen. Call your doctor if you have rash, hives, sores in your mouth, or blistering or peeling skin.
  • Gastrointestinal (GI) problems related to the pancreas, stomach, intestine, and colon can happen. If you have lymphoma that involves your stomach or intestine, you could have a higher risk of GI perforation (a hole in your stomach or intestine). Call your doctor if you have severe stomach pain, chills, fever, nausea, vomiting, or diarrhea.
  • High blood sugar. Your doctor will test your blood during ADCETRIS treatment. If your blood sugar is high, your doctor may give you medicine to control it. Call your doctor if you need to urinate more often, are very thirsty, or have blurry vision.

What were the most common side effects in patients treated with ADCETRIS?

When used alone or together with chemotherapy, the most common side effects were:

  • nerve damage (peripheral neuropathy)
  • feeling tired
  • nausea
  • diarrhea
  • a low number of white blood cells
  • infection in the nose or sinuses
  • fever
  • constipation
  • vomiting
  • hair loss
  • weight loss
  • upper stomach pain
  • a low number of red blood cells
  • sores or swelling in the mouth and/or in the digestive tract

Contact your doctor if you have any other side effects that bother you or do not go away.

What should I tell my doctor before I start treatment with ADCETRIS?

  • All your medical conditions, including if you have kidney, liver, or lung problems, an infection, or diabetes.
  • If you are pregnant or plan to become pregnant. ADCETRIS may harm your unborn baby. If you can get pregnant, you should have a pregnancy test before starting ADCETRIS treatment. You should use effective birth control (contraception) during ADCETRIS treatment and for at least 6 months after your last dose of ADCETRIS. Talk to your doctor about birth control methods. Tell your doctor right away if you become pregnant or think you are pregnant during ADCETRIS treatment. Men with female partners who can get pregnant should use effective birth control during ADCETRIS treatment and for 6 months after the last dose.
  • If you are breastfeeding or plan to breastfeed. Do not breastfeed during your ADCETRIS treatment.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ADCETRIS and certain other medicines can affect each other.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088.

Please see Important Facts about ADCETRIS including IMPORTANT WARNING

What is ADCETRIS?

ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat adult patients with:

  • Newly diagnosed Stage 3 or 4 classical Hodgkin lymphoma in combination with chemotherapy (adriamycin, vinblastine, and dacarbazine)
  • Classical Hodgkin lymphoma at high risk of coming back or becoming worse after a stem cell transplant
  • Classical Hodgkin lymphoma after a stem cell transplant fails or after at least 2 combination chemotherapy treatments fail and stem cell transplant is not an option
  • Newly diagnosed systemic anaplastic large cell lymphoma or other CD30-expressing peripheral T-cell lymphomas, including angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphomas not otherwise specified, in combination with chemotherapy (cyclophosphamide, doxorubicin, and prednisone)
  • Systemic anaplastic large cell lymphoma after at least 1 combination chemotherapy treatment fails
  • Primary cutaneous anaplastic large cell lymphoma or CD30-expressing mycosis fungoides who have received prior systemic therapy (treatment that reaches and affects the entire body)

Important Safety Information

What is the most important serious safety information I should know about ADCETRIS?

  • PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML): Patients treated with ADCETRIS can have a rare, serious brain infection called PML. It can cause death. Symptoms can begin at different times after starting ADCETRIS treatment, some within 3 months after the first dose. Call your doctor if you have mood changes, confusion, dizziness or loss of balance, trouble talking or walking, vision changes, or if you feel weak or have weakness on one side of the body. PML could also be caused by other treatments or diseases that made your immune system weaker.

What should I avoid when receiving ADCETRIS?

  • Do not take ADCETRIS with bleomycin because of possible serious side effects to the lungs.

What are the other possible serious side effects of ADCETRIS?

A serious side effect can be life-threatening or can lead to death. They may happen during treatment or after your treatment has ended.

Call your doctor right away if you have symptoms of a serious side effect or if your symptoms get worse. If you have a serious side effect, your doctor may delay or stop your ADCETRIS treatment.

  • Nerve damage (peripheral neuropathy) that is mostly numbness or tingling in the hands or feet (sensory) and/or weakness in the arms or legs (motor). The nerve damage can get worse with more doses of ADCETRIS. Call your doctor if you have tingling, burning, or numbness in your hands or feet, changes in your sense of touch, or trouble moving your hands or feet.
  • Allergic and infusion reactions during infusion or up to 24 hours after your ADCETRIS infusion. Call your doctor if you have fever, chills, rash, or breathing problems within 24 hours of your infusion.
  • Blood problems such as a low number of white blood cells with or without fever, a low number of platelets, or a low number of red blood cells.

    Your doctor will do blood tests to check your blood cell levels during ADCETRIS treatment. If your levels are too low, your doctor may lower or delay your dose, stop your ADCETRIS treatment, or give you a medicine called G-CSF. G-CSF is meant to prevent you from having a low number of white blood cells.

  • Infections such as pneumonia, bacteremia, and sepsis or septic shock can happen with ADCETRIS treatment. Call your doctor if you have a fever of 100.5°F or higher, chills, cough, or pain when you urinate.
  • Tumor lysis syndrome can happen if you have a tumor that grows quickly or have many tumor cells in your body.
  • Patients with severe kidney disease may have more side effects and deaths than patients with normal kidney function and should avoid treatment with ADCETRIS.
  • Patients with moderate or severe liver disease may have more side effects and deaths than patients with normal liver function and should avoid treatment with ADCETRIS.
  • Liver injury can happen after the first dose of ADCETRIS or after ADCETRIS treatment is stopped and started again. Call your doctor if you feel tired, do not feel like eating, have upper stomach pain, dark urine, or yellow skin and eyes (jaundice).
  • Lung problems. Call your doctor if you have a new cough, a cough that gets worse, or feel out of breath.
  • Skin problems called Stevens-Johnson syndrome and toxic epidermal necrolysis can happen. Call your doctor if you have rash, hives, sores in your mouth, or blistering or peeling skin.
  • Gastrointestinal (GI) problems related to the pancreas, stomach, intestine, and colon can happen. If you have lymphoma that involves your stomach or intestine, you could have a higher risk of GI perforation (a hole in your stomach or intestine). Call your doctor if you have severe stomach pain, chills, fever, nausea, vomiting, or diarrhea.
  • High blood sugar. Your doctor will test your blood during ADCETRIS treatment. If your blood sugar is high, your doctor may give you medicine to control it. Call your doctor if you need to urinate more often, are very thirsty, or have blurry vision.

What were the most common side effects in patients treated with ADCETRIS?

When used alone or together with chemotherapy, the most common side effects were:

  • nerve damage (peripheral neuropathy)
  • feeling tired
  • nausea
  • diarrhea
  • a low number of white blood cells
  • infection in the nose or sinuses
  • fever
  • constipation
  • vomiting
  • hair loss
  • weight loss
  • upper stomach pain
  • a low number of red blood cells
  • sores or swelling in the mouth and/or in the digestive tract

Contact your doctor if you have any other side effects that bother you or do not go away.

What should I tell my doctor before I start treatment with ADCETRIS?

  • All your medical conditions, including if you have kidney, liver, or lung problems, an infection, or diabetes.
  • If you are pregnant or plan to become pregnant. ADCETRIS may harm your unborn baby. If you can get pregnant, you should have a pregnancy test before starting ADCETRIS treatment. You should use effective birth control (contraception) during ADCETRIS treatment and for at least 6 months after your last dose of ADCETRIS. Talk to your doctor about birth control methods. Tell your doctor right away if you become pregnant or think you are pregnant during ADCETRIS treatment. Men with female partners who can get pregnant should use effective birth control during ADCETRIS treatment and for 6 months after the last dose.
  • If you are breastfeeding or plan to breastfeed. Do not breastfeed during your ADCETRIS treatment.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ADCETRIS and certain other medicines can affect each other.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088.

Please see Important Facts about ADCETRIS including IMPORTANT WARNING

What is ADCETRIS?

ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat adult patients with:

  • Newly diagnosed Stage 3 or 4 classical Hodgkin lymphoma in combination with chemotherapy (adriamycin, vinblastine, and dacarbazine)
  • Classical Hodgkin lymphoma at high risk of coming back or becoming worse after a stem cell transplant
  • Classical Hodgkin lymphoma after a stem cell transplant fails or after at least 2 combination chemotherapy treatments fail and stem cell transplant is not an option
  • Newly diagnosed systemic anaplastic large cell lymphoma or other CD30-expressing peripheral T-cell lymphomas, including angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphomas not otherwise specified, in combination with chemotherapy (cyclophosphamide, doxorubicin, and prednisone)
  • Systemic anaplastic large cell lymphoma after at least 1 combination chemotherapy treatment fails
  • Primary cutaneous anaplastic large cell lymphoma or CD30-expressing mycosis fungoides who have received prior systemic therapy (treatment that reaches and affects the entire body)

ADCETRIS and its logo, SeaGen Secure and its logo, and Seattle Genetics and , are US registered trademarks of Seattle Genetics, Inc.

© 2020 Seattle Genetics, Inc., Bothell, WA 98021

All rights reserved
US-BVP-20-241-MT